Enter assignee name

EPO Patents = 2

Forward Citations = 44

Loading Chart...

5 inventors (with patents filed for the assignee):

David Alan Campbell (9 out of 25 patents)

David T Winn (8 out of 21 patents)

Juan Manuel Betancort (7 out of 19 patents)

4. Zhen-Ping Wu (1 out of 2 patents)

5. Julie M Cherrington (1 out of 1 patent)

9 patents: Sort by Forward Citations

1. 8415295 - Heterocyclic boronic acid compounds (2013-04-09),

2. 8299271 - Solid tartrate salts of DPP-IV inhibitors (2012-10-30),

3. 7906658 - Pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IV (2011-03-15),

4. 7884217 - Pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IV (2011-02-08),

5. 7786312 - Methods of preparing heterocyclic boronic acids and derivatives thereof (2010-08-31),

6. 7767828 - Methyl and ethyl substituted pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IV (2010-08-03),

7. 7674913 - Heterocyclic boronic acid compounds (2010-03-09),

8. 7576121 - Pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IV (2009-08-18),

9. 7317109 - Pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-IV (2008-01-08),

Phenomix Corporation is a leading biotechnology company specializing in the discovery and development of novel therapeutics for metabolic diseases. Our innovative approach leverages cutting-edge technology to identify promising drug candidates that have the potential to address unmet medical needs in the field of diabetes, obesity, and other metabolic disorders.

Profile summary based on public USPTO records.